REAL-WORLD EVIDENCE RECOMMENDATIONS FOR GENE THERAPIES: REGULATORY VERSUS HEALTH TECHNOLOGY ASSESSMENT

被引：0
|
作者：
Allen, G. [1 ]
Summers, D. M. [1 ]
Evans, J. [1 ]
机构：
[1] Costello Med, Cambridge, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI43
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [31] Emulating Trials and Quantifying Bias: The Convergence of Health Technology Assessment Agency Real-World Evidence Guidance
    Chen, Simon
    Tikhonovsky, Natalie
    Dhanji, Nishit
    Ramagopalan, Sreeram
    VALUE IN HEALTH, 2024, 27 (02) : 265 - 267
  • [32] RESTRICTIONS AND REAL-WORLD EVIDENCE REQUIREMENTS IN THE HEALTH TECHNOLOGY ASSESSMENT OF GENE THERAPY MEDICINAL PRODUCTS IN EUROPE, CANADA, AUSTRALIA, AND THE UNITED STATES
    Hubscher, E.
    Wiltshire, L.
    Young, H. H., I
    Brackley, A.
    Ko, S.
    VALUE IN HEALTH, 2022, 25 (12) : S300 - S300
  • [33] Randomization versus Real-World Evidence REPLY
    Collins, Rory
    Bowman, Louise
    Landray, Martin
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (04):
  • [34] THE RACE TO IMPROVE HEALTH TECHNOLOGY ASSESSMENT OF GENE THERAPIES: WHICH COUNTRIES ARE EMBRACING RECOMMENDATIONS?
    Besley, S.
    Henderson, N.
    Napier, M.
    Hampson, G.
    Cole, A.
    Diamond, L.
    Gassman, S.
    Fortier, D.
    Kim, R.
    VALUE IN HEALTH, 2023, 26 (12) : S384 - S384
  • [35] The Use of Real-World Evidence for Regulatory Decisions in China
    Xu, Jiayue
    Wu, Wenkai
    Zhang, Xia
    Ren, Yan
    Yao, Minghong
    Liu, Mei
    Zou, Kang
    Wang, Wen
    Sun, Xin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 82 - 95
  • [36] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [37] Modernizing Regulatory Evidence with Trials and Real-World Studies
    Nancy A. Dreyer
    Marni Hall
    Jennifer B. Christian
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 1112 - 1115
  • [38] Modernizing Regulatory Evidence with Trials and Real-World Studies
    Dreyer, Nancy A.
    Hall, Marni
    Christian, Jennifer B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (05) : 1112 - 1115
  • [39] Should real-world evidence be incorporated into regulatory approvals?
    Spitzer, Ernest
    Cannon, Christopher P.
    Serruys, Patrick W.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1155 - 1159
  • [40] Examining the Use of Real-World Evidence in the Regulatory Process
    Beaulieu-Jones, Brett K.
    Finlayson, Samuel G.
    Yuan, William
    Altman, Russ B.
    Kohane, Isaac S.
    Prasad, Vinay
    Yu, Kun-Hsing
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 843 - 852
12345